Showing posts with label advocacy groups. Show all posts
Showing posts with label advocacy groups. Show all posts

Sunday, April 2, 2017

GOP Bill Could Let Employers Access Your Genetic and Health Info

A GOP bill in Congress could give employers access to employees’ personal medical and genetic information and increase financial penalties for people who reject workplace wellness programs. [1]


House Republicans have proposed this legislation that would make it easier for companies to gather DNA and health information from employees and their families – children included – when it’s collected as part of a ‘voluntary’ workplace wellness program. Debate still remains, however, on the effectiveness of such wellness programs in general. [2]


H.R. 1313, the Preserving Employee Wellness Programs Act, was proposed by Rep. Virginia Foxx, a Republican from North Carolina and chair of the House Committee on Education and the Workforce. The bill is under review by other House committees and is awaiting review by the Senate. It has drawn the ire of numerous consumer, health, and privacy advocacy groups, as well as House Democrats.




A spokesperson for the House committee argued that “the legislation will reaffirm existing law and provide regulatory clarity so that employers can have the certainty they need to help lower health care costs for their employees.” Opponents, however, say that the bill could undermine existing laws designed to protect an individual’s personal medical information from use by employers and others. [2]


In a statement, Nancy J. Cox, Ph.D., president of The American Society of Human Genetics, said:


“We urge the Committee not to move forward with consideration of this bill. As longtime advocates of genetic privacy, we instead encourage the Committee to pursue ways to foster workplace wellness and employee health without infringing upon the civil rights afforded by ADA (Americans with Disabilities Act) and GINA (Genetic Information Nondiscrimination Act).” [2]


GINA was intended to prohibit genetic discrimination, and passed Congress with bipartisan support in 2008. Under the bill, companies can neither hire nor fire workers on genetic grounds, and GINA banned employers from asking for DNA test results. Workplace wellness programs were the exception to the rule, but the information had to be given voluntarily and only the program director, not employers, would have access. [3]



When President Obama signed the Affordable Care Act into law in 2010, employers were given the power to levy financial incentives and penalties to urge employees to participate in the supposedly voluntary programs.


As of 1 January 2017, according to Equal Employment Opportunity Commission regulations, employees who opt out of a wellness program can face penalties of up to 30% more, or even 50% more under certain conditions, for work health insurance than those who participate in the program.


Under the Republican bill, employers can demand DNA test results for employees in wellness programs, which directly conflicts with the GINA ban on forcing workers to share their results. If the bill is passed, it would mean that the GINA provisions don’t apply to wellness programs.


Cox said that, if enacted, the bill would “fundamentally undermine” GINA and ADA. [2]


In a letter to Foxx, a group of advocates, including AARP, the American Diabetes Association, the American Academy of Pediatrics, the Epilepsy Foundation, the March of Dimes, and others wrote:


“We strongly oppose any legislation that would allow employers to inquire about employees’ private genetic information or medical information unrelated to their ability to do their jobs, and to impose draconian penalties on employees who choose to keep that information private.” [1]





Sources:


[1] The New York Times


[2] Fox News


[3] Buzzfeed



Storable Food


About Julie Fidler:


Author Image
Julie Fidler is a freelance writer, legal blogger, and the author of Adventures in Holy Matrimony: For Better or the Absolute Worst. She lives in Pennsylvania with her husband and two ridiculously spoiled cats. She occasionally pontificates on her blog.

Tuesday, October 18, 2016

The DEA Will Slash Opioid Production 25% in 2017

The U.S. Drug Enforcement Administration (DEA) announced on October 4th, 2016 that plans to reduce opioid manufacturing by 25% next year are underway, citing a shrinking market and the epidemic of abuse as primary reasons.

The official change, or Final Order, has been published in the Federal Register. And, as The Verge reports:




“The DEA reserves the right to change a quota based on reasons such as increased demand or new manufacturers entering the market.” [1]


Shrinking Demand, Shrinking Manufacture


From 1999 to 2014, sales of prescription opioids in the U.S. nearly quadrupled. Today, an estimated 20% of patients with non-cancer pain are prescribed the potent drugs. [1]


Since doctors are working to reduce the number of opioids they prescribe, the DEA is following suit by cutting down on the allowed quota.


Read: This NJ Hospital Will Do Anything to Avoid Prescribing Opioids


The DEA is making the move, even though pharmaceutical companies and advocacy groups spent $880 million on campaign contributions and lobbying initiatives from 2006 through 2015. That amount is 8 times what gun lobbyists spent, and 200 times more than advocates for stricter policies shelled out during the same time period.


The DEA sets a limit on the total amount of a drug that can be manufactured each year. Next year’s reduction in opioid medications will affect medications such as oxycodone, hydrocodone, morphine, hydromorphone, and fentanyl. [1]


Hydrocodone production will be cut by 34%.


In a press release, the DEA said:


“Earlier this year the CDC issued guidelines to practitioners recommending a reduction in prescribing opioid medication medications for chronic pain.




For years, DEA and others have been educating practitioners, pharmacists, manufacturers, and the public about the potential dangers of the misuse of opioid medications.” [1]


A Growing Crisis


Doctors wrote nearly 207 million prescriptions for narcotic painkillers in 2013 – a huge increase from about 76 million in 1991. This was in large part due to lobbying by the pharmaceutical industry and a PR campaign led by Purdue University to increase the use of the drugs. [3]


Purdue went on to plead guilty to misleading the public about the risk of addiction to the painkiller OxyContin, and paid a fine of $634.5 million.


CDC statistics show that more people died from drug overdoses in 2014 than in any year on record, and that opioids were involved in more than 6 out of 10 fatal overdoses. [1]


Sen. Richard Durbin of Illinois pointed out this past June that the DEA had approved enough opioid pills to be manufactured in 2014 “for every adult in America to have a bottle of pills.” [2]


Over the summer, a group of senators, including Durbin, called on the DEA to direct pharmaceutical companies to stem the supply of painkillers. Durbin wrote a letter to the administration, signed by a handful of his fellow lawmakers, which read:


“We urge the DEA to utilize its existing quota setting authority, to the fullest extent possible, to combat this epidemic.”


He went on to write:


“Fourteen billion opioid pills are now dispensed annually in the United States – enough for every adult American to have a bottle of pills.


Certainly, the pharmaceutical industry is at fault for decades of misleading information about their products and the medical community bears responsibility for its role in over-prescribing these dangerous and addictive drugs, but we remain deeply troubled by the sheer volume of opioids available – volumes that are approved by DEA.”


According to the 2015 National Survey on Drug Use and Health, upwards of 6.5 million Americans over age 12 have used opioids for non-medical use in the past month. Opioids are the second most popular drug after marijuana – and more popular than heroin, hallucinogens, and cocaine combined, in terms of use over the past month. [1]


Source: Business Insider

However, reducing the amount of prescription opioids can cause other problems. For example, in 2011, Florida Gov. Rick Scott started cracking down on pain-management clinics that were suspected of dispensing too many opioids.


The good news from Scott’s decision is that prescription-drug overdoses fell within the first year. The bad news is that heroin deaths climbed 39%, as people who couldn’t get their prescription painkillers turned to the illegal drug.


Meanwhile, the DEA decided in August 2016 not to reschedule marijuana from a Schedule I substance to a Schedule II substance. That means marijuana remains in the same group as heroin, LSD, peyote, ecstasy, quaaludes, and bath salts. Rescheduling marijuana would have made it legal for medical use nationwide.


Interestingly, cannabis has shown promise in studies in treating addictions to hard drugs, including opioids.


Sources:


[1] The Verge


[2] The Huffington Post


Business Insider


Storable Food


About Julie Fidler:


Author Image
Julie Fidler is a freelance writer, legal blogger, and the author of Adventures in Holy Matrimony: For Better or the Absolute Worst. She lives in Pennsylvania with her husband and two ridiculously spoiled cats. She occasionally pontificates on her blog.